Oncopeptides Weighing Pepaxto Withdrawal Request

 
• By Sue Sutter
  
Oncopeptides-FDA tug of war
The tug of war between FDA and Oncopeptides over withdrawal of Pepaxto continues. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image

More from Review Pathways

More from Pathways & Standards